Guest Editor Dr Vijay Chopra discusses the motivation behind the newly curated Special Focus on mineralocorticoid receptor antagonists.

Dr Chopra explores why this topic is more relevant than ever, particularly as the field moves beyond traditional aldosterone antagonists toward novel agents like finerenone and aldosterone synthase inhibitors.

From addressing hyperkalaemia fears to identifying gaps for future research, this conversation offers insights into Dr Chopra's Special Focus where you can find out more about the clinical implications of aldosterone inhibition, both for current practice and what's on the horizon.

Explore the full Special Focus collection featuring insightful articles by leading experts, including Dr Dinesh Khullar, Prof Javed Butler, Dr Rishi Sethi, Dr Pravesh Vishwakarma, Dr Subodh Verma, and others.